Newsletter
Utilizing Virtual Reality for Digital Therapeutics

DTx Podcast with Eugene Borukhovich

Utilizing Virtual Reality for Digital Therapeutics

November 1, 2022

Utilizing Virtual Reality for Digital Therapeutics

In this episode, we hear from Sammeli Liikkanen, Digital Medicines Director at Orion Corporation. Orion Pharma is a globally operating Finnish pharmaceutical company with core therapy areas of neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases.

In this episode, we cover:

  • How Orion approaches non-molecular innovation
  • Solving misconceptions in digital medicine
  • VR as a modality for DTx
  • Patient experience using VR
  • Approaches to evidence generation
  • Commercializing stand alone DTx vs Drug+

Guest Links and Resources:

Host Links:

Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Join Our Newsletter

Proudly supported by:

cover
A Diverse Skill Set Peter McCanna is chief executive officer (CEO) at Baylor Scott & White Health, the largest not- for-profit health system in Texas. Through 51 hospitals and more than 1,200 access points, including flagship academic medical centers in Dallas, Fort Worth and Temple, the system offers the full continuum of care, from primary to award-winning specialty care, as well as an array of virtual and in-home services.